Author:
Yu Hyeon,Commander Clayton W.
Publisher
Springer International Publishing
Reference97 articles.
1. Conn JW, Cohen EL, Rovner DR, Nesbit RM. Normokalemic primary aldosteronism. A detectable cause of curable “essential” hypertension. JAMA. 1965;193:200–6.
2. Conn JW, Cohen EL, Rovner DR. Suppression of plasma renin activity in primary aldosteronism. JAMA. 1964;190:213–21.
3. Conn JW, Louis LH. Primary aldosteronism, a new clinical entity. Ann Intern Med. 1956;44(1):1–15.
4. Conn JW, Louis LH. Primary aldosteronism: a new clinical entity. Trans Assoc Am Phys. 1955;68:215–31. discussion 31–3
5. Mulatero P, Monticone S, Deinum J, et al. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. J Hypertens. 2020;38(10):1919–28.